AARD vs FLT
Aardvark Therapeutics, Inc. Common Stock (AARD) versus FLT (FLT) — a side-by-side from cached financials, not a winner call.
Aardvark Therapeutics, Inc. Common Stock (AARD) is a biotechnology company listed on US.
FLT (FLT) common stock.
Latest reported AARD revenue for 2025-12-31 was $0. Net income was -$57.6M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. AARD currently screens at market cap $284.4M.
FLT does not have a complete income-statement cache yet.
AARD currently screens at market cap $284.4M.
Not investment advice. Open the AARD and FLT stock pages for the full models.
Not investment advice.